Ernst & Young (EY for the hip kids) conducted a 6,000 person study across six countries to determine what patients value in their healthcare system. Access and ease of navigation were the top satisfiers.

Most patients still prefer in-person care, mainly to ensure their doctors understand the symptoms and condition. However, that doesn't rule out virtual care completely, 77% of Americans would at least consider it.

Perhaps of most interest to pharma marketers is that the number one use of telemedicine for patients in the USA is prescription renewal.

The countries studied were United States, Australia, Canada, Ireland, England and Germany. Grab a copy of the full report to see breakdowns of all the countries.

An academic paper, published in Nature, looks at using AI in a NYC hospital to predict five elements of patient care: 

The author doesn't pretend to know the math going on here (our Labs folks would -Ed.) but for insurance rejection and length of stay (LOS) predictions the AI seems to be outperforming the benchmark.

If you're AI and math oriented jump on over to the Nature paper.

Klick's btwelve group has a new POV out on food as medicine. This POV has information for those just getting into marketing these products but also touches on whether or not to go after insurance reimbursement.

There's a big "however" to this statement though. Grab the full POV to discover that and many other insights.

PEW Research typically does quantitative surveys but sometimes also produces qualitative research. This report is one of those times. The report is based on five focus groups with a total of 23 individuals contributing. We will just touch on a few of the highlight quotes for each platform.

There are four other sections in the PEW report:

A study from Virgin about companies' wellbeing priorities includes some data on how they communicate about these programs. HR folks might be interested in the other content but even marketers who sometimes struggle to get their messages out to the workforce can benefit from some of this data. 

When it comes to communicating with the workforce email is still number one. For good reason too, it's guaranteed to be delivered and it can be searched later. 

Mental health continues to be the primary concern for wellbeing programs, seven of nine (that's a coincidence, not a Star Trek reference) countries have either Mental Health or Stress Management as their top priority.

If you're interested in benefits programs or even just how to communicate internally this report will have something for you.

A new study looks at distributed clinical trials (DCTs) globally (but with a focus on North America). The technologies most used in these trials start with telemedicine but then get much more specialized.

As we can see from a five-point scale for importance, patient convenience and the highly-related retention are top of the list. 

GlobalData has done a listening exercise of pharma companies' talk on social media (mainly Twitter and other public platforms). These companies are talking about "big data" a lot. The authors charted something called "IndexVal" which we will assume is the topic indexed against the average (but to be clear, this is an assumption on our part).

If our assumption is correct then pharma talked about "big data" between 3x and 5x more than the average over the past three years.

The report also highlights some of the more prolific thought leaders in the space. Atanasov had the most with 11 mentions in Q1 2023.

This is corporate listening and will not include brands, which we consider the more important data sources. If you want to know about brands, Klick Social Strategy has a list of over 930 branded, unbranded, and corporate Meta properties and can use Meltwater to see what any of them are saying (opportunistic, I like it -Ed.).

We were all excited to see that Elon Musk had named Linda Yaccarino the new CEO but there are still signals coming out of the organization that it's not a safe place for pharma advertising. 

In this case it's the head of brand safety and ad quality, A.J. Brown, leaving the company. Brown did not have any acrimonious departing words, but the fact that they and Ella Irwin, vice president of product for trust and safety, have left in the same week doesn't send a reassuring message to advertisers.

The key to successful cancer treatment is early detection. We all know that but many of the tools that allow for that detection are expensive and time-consuming (and so, not covered by insurance for routine checkups).  

But, what if you could get a full-body MRI scan in 30 minutes?

Thanks, Liveramp! The company has made the eMarketer US Ad Spending 2023 report available for free. This report looks at many channels and we're highlighting Connected TV and Social here.

Here we see CTV over $40 billion by 2027 with growth around 11%. Looking at social we see a much higher amount, $82 billion, with a slightly lower growth at 9.5%.

We were attracted to this story strictly because of the AI element in the second section. When we saw this idea it was immediately apparent that it would be hugely valuable for the right team. 

Essentially, the tip is to train ChatGPT on your brand and then retain that chat so that the context does not reset. The ideas from the author were to train ChatGPT on:

The above is for a small business but brand marketers will see obvious ways to convert the information to their product. Then you tell ChatGPT to remember this information:

Note that everything you put into ChatGPT becomes part of its common data repository. If your company policies forbid this then you'll need to get them changed or not use this technique. 

* Yes, that's a lost in space reference.

Statista showed some data from Accenture on what industries could see more disruption from AI in terms of work hours displaced. Health was relatively low on the list.